Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Holders of 5% or more of CLNN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Clene Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Mosca Alison | 13G/A | 19.70%1.89M shares | – | Feb 12, 20251 filing | Feb 12, 2025 | SEC |
| 4LIFE Research LLC | 13G/A | 6.50%555.3K shares | – | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
5 Schedule 13D and 13G filings on Clene Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 20252:15 PM ET | AWM Investment Company, Inc. | 13G/A | 4.70%500.0K shares | −1.00 ppfrom 5.70%Below 5% | Sep 30, 2025 | SEC |
| Feb 14, 20259:07 PM ET | 4LIFE Research LLCand 1 other | 13G/A | 6.50%555.3K shares | – | Dec 20, 2024 | SEC |
| Feb 14, 20255:33 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%419.1K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20252:57 PM ET | AWM Investment Company, Inc. | 13G/A | 5.70%500.0K shares | – | Dec 31, 2024 | SEC |
| Feb 12, 20257:01 AM ET | Mosca Alison | 13G/A | 19.70%1.89M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Clene Inc. shares.
No Form 144 notices for Clene Inc. are on file.